Chester County News and Community Website
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) has announced the publication of a groundbreaking study in the prestigious journal Brain Stimulation. The research provides new insights into the effectiveness of …
New Study Offers Hope for Depression Patients Undergoing TMS Therapy Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), the makers of NeuroStar Advanced Therapy, recently announced vital healthcare policy updates from Magellan, BlueCross BlueShield (BCBS) of Kansas City, and Dean Health …
Neuronetics Gets Healthcare Policy Boost: Increased Patient Access to NeuroStar Therapy Read More
Seasonal depression, also known as Seasonal Affective Disorder (SAD), is a type of depression that comes and goes with the seasons. Typically, it starts in late fall and early winter …
Unmasking Seasonal Depression: Hacks to Brighten Your Mood Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), in recognition of National Suicide Prevention Awareness Month, announced the launch of the NeuroStar Voices Portal, a platform aimed at fostering connections, sharing …
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression Read More
The U.S. Food and Drug Administration recently approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically occurs …
FDA Approves Zurzuvae: Game-Changing Medication for Postpartum Depression Read More